These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 25041864

  • 1. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M, Vermeire S, Van Oijen M, Vleggaar F, Siersema P, van Assche G, Rutgeerts P, Oldenburg B, Dutch Initiative on Crohn and Colitis.
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [Abstract] [Full Text] [Related]

  • 2. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Jan; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 3. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.
    Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898
    [Abstract] [Full Text] [Related]

  • 4. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE, Looman CW, Steyerberg EW, Beukers R, Tan AC, Weusten BL, Kuipers EJ, van der Woude CJ.
    Am J Gastroenterol; 2011 Feb 27; 106(2):319-28. PubMed ID: 21045815
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS, Park SH, Yang SK, Ye BD, Kim JH, Kim SO, Soh JS, Lee S, Bae JH, Lee HJ, Yang DH, Kim KJ, Byeon JS, Myung SJ, Yoon YS, Yu CS, Kim JH.
    Scand J Gastroenterol; 2015 Feb 27; 50(2):188-96. PubMed ID: 25515241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J.
    Clin Gastroenterol Hepatol; 2018 Jul 27; 16(7):1106-1113.e3. PubMed ID: 29378311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
    Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, van Nieuwkerk KM, Drenth JP, Witteman BJ, Tuynman HA, Naber AH, Kingma PJ, van Buuren HR, van Hoek B, Vleggaar FP, van Geloven N, Beuers U, Ponsioen CY, EpiPSCPBC Study Group.
    Hepatology; 2013 Dec 27; 58(6):2045-55. PubMed ID: 23775876
    [Abstract] [Full Text] [Related]

  • 11. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov 27; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

  • 12. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW.
    Clin Gastroenterol Hepatol; 2012 Mar 27; 10(3):303-8. PubMed ID: 22037429
    [Abstract] [Full Text] [Related]

  • 13. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
    Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyöty M, Nieminen I, Hemminki H, Collin P.
    J Crohns Colitis; 2013 Dec 27; 7(11):e551-7. PubMed ID: 23619008
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess T.
    Liver Int; 2018 Mar 27; 38(3):532-541. PubMed ID: 28796371
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease.
    Selinger CP, Andrews JM, Titman A, Norton I, Jones DB, McDonald C, Barr G, Selby W, Leong RW, Sydney IBD Cohort Study Group.
    Clin Gastroenterol Hepatol; 2014 Apr 27; 12(4):644-50. PubMed ID: 23707778
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P, Sonnenberg A.
    Am J Gastroenterol; 1996 Jan 27; 91(1):44-8. PubMed ID: 8561142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.